Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
2025 Global Fluorescence Immunoassay Analyzers Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
Oncology Companion Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More
-
Diabetes Diagnostics
... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Hematology Instruments and Reagents
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$15.4 ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
First Aid Kits
... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More
-
DNA Probes-Based Diagnostics
... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end of ... Read More
-
2025 Global Fully Automated Coagulation Analyzer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Microtomes
... 6.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth in ... Read More
-
Spectroscopy Equipment and Accessories
... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Molecular Spectroscopy, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$7.6 Billion by the ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More
-
2025 Global Female Fertility And Pregnancy Rapid Test Market Industry (2031 Outlook)
... market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by the ... Read More
-
Digital Pathology Systems
... at a CAGR of 12.8% over the analysis period 2024-2030. Device, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Metabolic Testing Solutions
... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
Veterinary Rapid Testing
... at a CAGR of 8.3% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More
-
Titrators (Automatic and Manual)
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Coulometric, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$334.3 Million by the end ... Read More
Research Assistance
